Literature DB >> 17139649

Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor.

Harald A Hall1, Bernard Zimmermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17139649     DOI： 10.1002/art.22358

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  11 in total

1.  Tumor necrosis factor inhibitor-associated dermatomyositis.

Authors:  Rachel Klein; Misha Rosenbach; Ellen J Kim; Brian Kim; Victoria P Werth; Jonathan Dunham
Journal:  Arch Dermatol       Date:  2010-07

2.  Is dermatomyositis in patients with rheumatoid arthritis induced by anti-TNF-α therapy?

Authors:  Alexandra Maria Giovanna Brunasso; Cesare Massone
Journal:  Clin Rheumatol       Date:  2011-01-11       Impact factor: 2.980

Review 3.  Recent Advances in Pharmacological Treatments of Adult Dermatomyositis.

Authors:  Kristen L Chen; Majid Zeidi; Victoria P Werth
Journal:  Curr Rheumatol Rep       Date:  2019-08-31       Impact factor: 4.592

4.  Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature.

Authors:  Yuki Ishikawa; Naoichiro Yukawa; Koichiro Ohmura; Yuji Hosono; Yoshitaka Imura; Daisuke Kawabata; Takaki Nojima; Takao Fujii; Takashi Usui; Tsuneyo Mimori
Journal:  Clin Rheumatol       Date:  2010-02-09       Impact factor: 2.980

Review 5.  The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors:  Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

6.  A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept.

Authors:  Yuki Ishikawa; Naoichiro Yukawa; Daisuke Kawabata; Koichiro Ohmura; Takao Fujii; Takashi Usui; Tsuneyo Mimori
Journal:  Clin Rheumatol       Date:  2011-01-11       Impact factor: 2.980

7.  High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis.

Authors:  Ayako Nakajima; Koichiro Yoshino; Makoto Soejima; Yasushi Kawaguchi; Takashi Satoh; Masataka Kuwana; Hisashi Yamanaka
Journal:  Rheumatol Int       Date:  2011-04-11       Impact factor: 2.631

Review 8.  Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies.

Authors:  Namita A Goyal; Tahseen Mozaffar
Journal:  Curr Treat Options Neurol       Date:  2018-07-23       Impact factor: 3.598

Review 9.  Cutaneous dermatomyositis in the era of biologicals.

Authors:  Natalie A Wright; Ruth Ann Vleugels; Jeffrey P Callen
Journal:  Semin Immunopathol       Date:  2015-11-12       Impact factor: 9.623

Review 10.  Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2011-01-21       Impact factor: 6.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.